Company Overview
Snapshot
Founded in March 2022 by Albert Kashchenevsky, Eyecuracy operates with 1–10 employees. The company has raised $1.3 million across one funding round from one investor, Random Forest VC. Eyecuracy is currently in the clinical trial phase for its diagnostic and monitoring platform for neurological and neuro-ophthalmological disorders.
Business overview
Eyecuracy develops a hybrid healthcare platform for the diagnostics, monitoring, and treatment of neurological and neuro-ophthalmological disorders. Its core technology features a user-friendly hardware device, a smart cloud service, and proprietary AI algorithms for accurate eye tracking. The platform aims to provide convenient and cost-effective patient care through in-office diagnosis, home monitoring, and therapy, addressing challenges in traditional diagnostic methods. Eyecuracy serves the healthcare industry, specifically targeting hospitals and healthcare providers with its SaaS, computer vision, and machine learning solutions for eye diseases and remote monitoring in markets across Europe, North America, and Asia.
Log in to access full profile ›Company Intelligence Q&A
- What is Eyecuracy's primary focus?
- Eyecuracy specializes in developing an AI-powered hybrid healthcare platform for the diagnostics, monitoring, and treatment of neurological and neuro-ophthalmological disorders.
- Who founded Eyecuracy?
- Eyecuracy was founded by Albert Kashchenevsky, who also serves as the CEO.
- When was Eyecuracy founded?
- Eyecuracy was founded in March 2022.
- What is Eyecuracy's core technological advantage?
- Eyecuracy's core technology utilizes a unique AI-powered eye tracking algorithm that accurately locates the optical axis by going to the cornea perimeter (the limbus), unlike other solutions that rely on infrared cornea reflections.
- What is the current product stage of Eyecuracy's solution?
- Eyecuracy's solution is currently in the clinical trial stage, with ongoing trials to validate its effectiveness and safety for diagnosing, monitoring, and treating neurological and neuro-ophthalmological disorders.